The Role of Intrinsically Disordered Domains in Regulating G Protein-Coupled Receptor Signaling.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• The alpha-2A adrenergic receptor (α2AAR) is a key therapeutic target for hypertension, diabetes, and chronic pain.
• Understanding α2AAR activation mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the agonist-specific activation dynamics of α2AAR using single-molecule imaging.
• To elucidate the roles of both structured transmembrane domains (TMD) and intrinsically disordered regions (IDRs) in α2AAR signaling.

Main Methods:

• Single-molecule fluorescence resonance energy transfer (smFRET) imaging.
• Systematic investigation of real-time conformational changes using seven pairs of fluorophore labels.
• Characterization of dynamics in TMD, extracellular loop 2 (ECL2), and intracellular loop 3 (ICL3).

Main Results:

• Revealed unique TM6 dynamics with a high energy barrier for agonist-induced activation.
• Identified agonist-specific conformational dynamics in the ECL2, acting as a regulatory module.
• Characterized ICL3 as a compact, membrane-proximal negative allosteric regulator, with functional substates modulated by phosphorylation and drug efficacy.

Conclusions:

• α2AAR function is governed by complex dynamics in both its structured TMD and disordered regions (IDRs).
• Agonist-specific activation pathways involve distinct conformational changes in key receptor domains.
• These insights provide a foundation for designing novel therapeutics targeting α2AAR signaling pathways.